T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,570.00
+70.00 (2.80%)
At close: Dec 5, 2025
-45.32%
Market Cap 115.50B
Revenue (ttm) 20.67B
Net Income (ttm) -9.61B
Shares Out 44.94M
EPS (ttm) -371.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,050,395
Average Volume 3,286,017
Open 2,540.00
Previous Close 2,500.00
Day's Range 2,430.00 - 2,580.00
52-Week Range 1,127.00 - 4,808.33
Beta 0.15
RSI 77.63
Earnings Date Nov 21, 2025

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Employees 86
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.